FDA suspicious of 23andMe genome-testing kit, demands evaluation

So why is the FDA taking action to block 23andMe after years of allowing the product to be sold? According to the letter, 23andMe has increased the number of claims it makes for its product regarding the total number of genetic factors it can analyze and the conditions it detects — but has failed to submit proof of the efficacy of its detection methods or the error rate.
BlackListedNews.com